View in EDS

Differentiation latency, cell division symmetry, and dormancy signatures define fetal liver HSCs at single cell resolution.

Saved in:
Bibliographic Details
Title: Differentiation latency, cell division symmetry, and dormancy signatures define fetal liver HSCs at single cell resolution.
Authors: Ishida T; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Mercoli J; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Heck AM; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Phelps I; Department of Pediatrics, University of Washington, Seattle, WA., Varnum-Finney B; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Dozono S; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Nourigat-McKay C; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Kraskouskas K; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Wellington R; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Waltner O; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Department of Genome Sciences, University of Washington, Seattle, WA, USA., Jackson DL; Department of Genome Sciences, University of Washington, Seattle, WA, USA., Delaney C; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Deverra Therapeutics, Seattle, WA, USA.; Division of Pediatric Hematology/Oncology, University of Washington, Seattle, WA,USA., Rafii S; Division of Regenerative Medicine, Ansary Stem Cell Institute, Department of Medicine, Weill Cornell Medicine, New York, NY, USA., Bernstein ID; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Division of Pediatric Hematology/Oncology, University of Washington, Seattle, WA,USA., Aldinger KA; Department of Pediatrics, University of Washington, Seattle, WA.; Department of Neurology, University of Washington, Seattle, WA.; Norcliffe Foundation Center for Integrative Brain Research, Seattle Children's Research Institute, Seattle, WA., Trapnell C; Department of Genome Sciences, University of Washington, Seattle, WA, USA., Zhao HG; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA., Hadland B; Translational Science and Therapeutics Division, Fred Hutchinson Cancer Center, Seattle, WA, USA.; Division of Pediatric Hematology/Oncology, University of Washington, Seattle, WA,USA.
Corporate Authors: Birth Defects Research Laboratory (BDRL)
Source: BioRxiv : the preprint server for biology [bioRxiv] 2025 May 02. Date of Electronic Publication: 2025 May 02.
Publication Type: Journal Article; Preprint
Journal Info: Country of Publication: United States NLM ID: 101680187 Publication Model: Electronic Cited Medium: Internet ISSN: 2692-8205 (Electronic) Linking ISSN: 26928205 NLM ISO Abbreviation: bioRxiv Subsets: PubMed not MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2692-8205
DOI:10.1101/2023.06.01.543314